Experts from technology transfer, scientists and founders will meet potential licensees and investors from the biotech and pharmaceutical industry during BioVaria 2026 on 27 and 28 April at the Sofitel Munich. The interactive program focuses every year on outstanding development and start-up projects from European research institutes, universities and university hospitals, as well as comprehensive networking.
A total of around 70 selected licensable life-science technologies will be presented, about 30 of them in oral sessions. They include new therapeutical and diagnostic approaches as well as innovative platform technologies. Once again, young scientists will present their early-stage innovation projects including several from Ascenion’s Life Science Digital Hub, which is supported by GO-Bio initial.
The Startup Pitch & Partner programme has been an integral part of BioVaria for years. It features selected start-ups who will pitch their projects in front of the complete audience with the chance to win one of two BioVaria Awards, endowed with up to EUR 2,000. In addition, the teams have the opportunity to provide investors with a deeper understanding of their idea in an exclusive speed-dating session. Start-ups interested in participating may apply online by 15 February.
BioVaria is jointly organised by Ascenion and a selected group of European technology transfer organisations.
Application for Startup Pitch & Partner 2026
Follow uns on LinkedIn for regular updates!
